<SEC-DOCUMENT>0001193125-15-388871.txt : 20151125
<SEC-HEADER>0001193125-15-388871.hdr.sgml : 20151125
<ACCEPTANCE-DATETIME>20151125171105
ACCESSION NUMBER:		0001193125-15-388871
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20151119
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20151125
DATE AS OF CHANGE:		20151125

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MANNKIND CORP
		CENTRAL INDEX KEY:			0000899460
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133607736
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50865
		FILM NUMBER:		151256757

	BUSINESS ADDRESS:	
		STREET 1:		25134 RYE CANYON LOOP
		STREET 2:		SUITE 300
		CITY:			VALENCIA
		STATE:			CA
		ZIP:			91355
		BUSINESS PHONE:		6617755300

	MAIL ADDRESS:	
		STREET 1:		25134 RYE CANYON LOOP
		STREET 2:		SUITE 300
		CITY:			VALENCIA
		STATE:			CA
		ZIP:			91355
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d21808d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): November&nbsp;19, 2015 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>MannKind Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>000-50865</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>13-3607736</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction&nbsp;of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>25134 Rye Canyon Loop, Suite 300</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Valencia, California</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>91355</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: (661)&nbsp;775-5300 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N/A </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or
former address, if changed since last report.) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. of Form 8-K): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.02</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&nbsp;19, 2015, Hakan S. Edstrom resigned as the
President, Chief Executive Officer and as a director of MannKind Corporation (the &#147;Company&#148;), effective immediately. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&nbsp;19, 2015, in light of Mr.&nbsp;Edstrom&#146;s resignation as the Company&#146;s President and Chief Executive Officer, the Company&#146;s
Board of Directors appointed Alfred E. Mann to the position of interim Chief Executive Officer. Mr.&nbsp;Mann also continues to serve as the Company&#146;s Executive Chairman of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Mann, age 90, has been one of the Company&#146;s directors since April 1999, the Company&#146;s Executive Chairman of the Board since January 2015
and, before that, the Company&#146;s Chairman of the Board from December 2001 until January 2015. Mr.&nbsp;Mann also previously served as the Company&#146;s Chief Executive Officer from October 2003 until January 2015. Mr.&nbsp;Mann founded and
formerly served as Chairman and Chief Executive Officer of MiniMed, Inc., a publicly traded company focused on diabetes therapy and microinfusion drug delivery that was acquired by Medtronic, Inc. in August 2001. He also founded, and from 1972
through 1992 served as Chief Executive Officer of, Pacesetter Systems, Inc. and its successor, Siemens Pacesetter, Inc., a manufacturer of cardiac pacemakers, now the Cardiac Rhythm Management Division of St. Jude Medical Corporation. Mr.&nbsp;Mann
founded, and since 1993 has served as Chairman and until January 2008 as Co-Chief Executive Officer of, Advanced Bionics Corporation, a medical device manufacturer focused on neurostimulation to restore hearing to the deaf and to treat chronic pain
and other neural deficits. Mr.&nbsp;Mann has also founded and is non-executive Chairman of Second Sight Medical Products, Inc., which is developing a visual prosthesis for the blind; Bioness Inc., which is developing rehabilitation neurostimulation
systems; Quallion LLC, which produces batteries for medical products and for the military and aerospace industries; and Stellar Microelectronics Inc., a supplier of electronic assemblies to the medical, military and aerospace industries.
Mr.&nbsp;Mann also founded and is the managing member of PerQFlo, LLC, which is developing drug delivery systems. Mr.&nbsp;Mann is the managing member of the Alfred E. Mann Foundation and is also non-executive Chairman of Alfred Mann Institutes at
the University of Southern California, AMI Purdue and AMI Technion, and the Alfred Mann Foundation for Biomedical Engineering, which is establishing additional institutes at other research universities. Mr.&nbsp;Mann holds bachelor&#146;s and
master&#146;s degrees in Physics from the University of California at Los Angeles, honorary doctorates from Johns Hopkins University, the University of Southern California, Western University and the Technion-Israel Institute of Technology and is a
member of the National Academy of Engineering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is the borrower under a loan arrangement with The Mann Group LLC (the &#147;Loan
Arrangement&#148;), an entity of which Mr.&nbsp;Mann is the sole member and manager. Outstanding principal under the Loan Arrangement bears interest at a fixed annual rate of 5.84%. Interest is due and payable quarterly in arrears on the first day
of each calendar quarter for the preceding quarter, or at such other time as the Company and The Mann Group mutually agree. All or any portion of accrued and unpaid interest that becomes due and payable may be paid-in-kind and capitalized as
additional borrowings at any time upon agreement of the parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The current outstanding principal amount under the Loan Arrangement, which is also the
largest outstanding principal amount under the Loan Arrangement since January&nbsp;1, 2014, is $49,520,906. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1, 2014, the Company has
not repaid any of the outstanding principal under the Loan Arrangement or accrued interest thereon. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with Mr. Edstrom&#146;s resignation, the Company and Mr. Edstrom have reached a preliminary agreement regarding the terms of Mr. Edstrom&#146;s
separation from the Company (the &#147;proposed separation agreement&#148;). Pursuant to the proposed separation agreement, and provided that Mr.&nbsp;Edstrom does not revoke his acceptance of the agreement once reduced to writing, Mr.&nbsp;Edstrom
would provide the Company with a general release of claims and remain employed with the Company to provide transition and other services through July&nbsp;1, 2017, subject to his earlier resignation or termination by the Company. Mr.&nbsp;Edstrom
would report to the Company&#146;s principal executive officer during the term of the agreement. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Edstrom would be entitled to receive his base salary in effect at the time of his resignation.
Mr.&nbsp;Edstrom would also be eligible to receive an annual bonus for 2015 in an amount equal to his average annual bonus for the past three years, but would not be entitled to receive an annual bonus for any services he performs in 2016 or 2017.
The terms of the proposed separation agreement are preliminary and non-binding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&nbsp;20, 2015, the Company issued a press release announcing
the resignation of Mr.&nbsp;Edstrom and appointment of Mr.&nbsp;Mann, which is attached hereto as Exhibit 99.1. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(d) Exhibits </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:25.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit<BR>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press release dated November&nbsp;20, 2015</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Statements in this report that are not strictly historical in nature are forward-looking statements within the meaning of Section&nbsp;21E of the Securities
Exchange Act of 1934, as amended. These forward-looking statements include, without limitation, statements relating to the interim nature of Mr.&nbsp;Mann&#146;s service as the Company&#146;s Chief Executive Officer and the consideration to be
provided and services to be performed pursuant to the proposed separation agreement with Mr.&nbsp;Edstrom. Words such as &#147;believes&#148;, &#147;anticipates&#148;, &#147;plans&#148;, &#147;expects&#148;, &#147;intends&#148;, &#147;will&#148;,
&#147;potential&#148; and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon the Company&#146;s current expectations and involve a number of risks and uncertainties, including the
risk that the Company and Mr. Edstrom may not enter into a final, binding separation agreement and the risks and uncertainties described in the Company&#146;s annual report on Form 10-K for the year ended December&nbsp;31, 2014 and subsequent
quarterly reports on Form 10-Q filed with the Securities and Exchange Commission. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties.
You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. All forward-looking statements are qualified in their entirety by this cautionary statement, and the Company
undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this report. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date: November 25, 2015</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>MANNKIND&nbsp;CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Thomson</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David&nbsp;Thomson,&nbsp;Ph.D.,&nbsp;J.D.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Corporate Vice President, General Counsel and Secretary</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:25.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit<BR>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press release dated November&nbsp;20, 2015</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d21808dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g21808g73i57.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November&nbsp;20, 2015 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>MannKind Announces Senior Management Changes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VALENCIA,
Calif., Nov. 20, 2015 (GLOBE NEWSWIRE)&#151;<B>MannKind Corporation</B> (NASDAQ:MNKD) and (TASE:MNKD) today announced that Hakan Edstrom has stepped down as the President, Chief Executive Officer and as a director of MannKind. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The board of directors of MannKind appointed Alfred Mann as interim Chief Executive Officer, effective November&nbsp;19, 2015. Mr.&nbsp;Mann will continue to
serve as the Executive Chairman of the Company. A committee of the board will commence an immediate search for a successor CEO. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About MannKind
Corporation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MannKind Corporation (Nasdaq:MNKD) and (TASE:MNKD) focuses on the discovery and development of therapeutic products for patients with
diseases such as diabetes. MannKind maintains a website at <U>http://www.mannkindcorp.com</U> to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the
MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CONTACT:&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Company Contact:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Matthew J. Pfeffer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">661-775-5300</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><U>mpfeffer@mannkindcorp.com</U></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g21808g54r88.jpg" ALT="LOGO">
 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g21808g54r88.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g21808g54r88.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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%110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g21808g73i57.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g21808g73i57.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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M79F&7?5L%AZ\])5%)V\DU9_/\K')@L=[;%5Z<=8PY;/S:U-&BO,?@)^U_P"
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M[_>S\<_V=?'#?';X$?"SP)J?C&XO(V^,%QI<]OI>KW'G)IQMI75$=R)A V,
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M=^-_Q%TOX]ZWJ'PK3PEX/T:X^'?A^UU1X;>R5[%3=&T:$HMY/%=KY6T#)6-
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<@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
